Glycopyrrolate
- Product NDC
- 70710-1646
- 11-digit product format
- 707101646
- Labeler code
- 70710
- Product ID
- 70710-1646_c56593be-a843-4885-8af8-c8535654ef1d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Glycopyrrolate
- Dosage form
- INJECTION
- Route
- INTRAMUSCULAR; INTRAVENOUS
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Application
- ANDA214213
- Marketing category
- ANDA
- Marketing start
- 2021-11-18
- Marketing end
- 0000-00-00
- Substance
- GLYCOPYRROLATE
- Active strength
- 0 mg/mL
- Pharmacologic classes
- Anticholinergic [EPC], Cholinergic Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70710-1646 | GLYCOPYRROLATE INJECTION [ZYDUS PHARMACEUTICALS USA INC.] | 2 | Legacy NDC | 20221118_90974a9f-c664-49b8-8d23-182286becc7c.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70710-1646-7 | 70710164607 | 25 VIAL in 1 CARTON (70710-1646-7) > 2 mL in 1 VIAL (70710-1646-1) | 25 vial | 2021-11-18 | 0000-00-00 | No | No | Current |